BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2457617)

  • 1. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
    Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
    J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limiting dilution analysis of Epstein-Barr virus infectable B cells secreting anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus erythematosus and systemic lupus erythematosus.
    Isacovics B; Silverman ED
    J Autoimmun; 1993 Aug; 6(4):481-94. PubMed ID: 8216690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus.
    Furukawa F; Kashihara-Sawami M; Lyons MB; Norris DA
    J Invest Dermatol; 1990 Jan; 94(1):77-85. PubMed ID: 2132545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of anti-Ro/SS-A and anti-La/SS-B activity of human serum monoclonal immunoglobulins (monoclonal gammopathies).
    Buskila D; Weigl D; Shoenfeld Y
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):75-80. PubMed ID: 1633268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic effect on human keratinocytes caused by anti-Ro-(SS-A) antibodies and UVA in vitro].
    Brink I; Böhm F; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1990; 176(11):701-6. PubMed ID: 2083611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.
    Furukawa F; Itoh T; Wakita H; Yagi H; Tokura Y; Norris DA; Takigawa M
    Clin Exp Immunol; 1999 Oct; 118(1):164-70. PubMed ID: 10540174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.
    Gordon P; Khamashta MA; Rosenthal E; Simpson JM; Sharland G; Brucato A; Franceschini F; De Bosschere K; Meheus L; Meroni PL; Hughes GR; Buyon J
    J Rheumatol; 2004 Dec; 31(12):2480-7. PubMed ID: 15570655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro/SSA and La/SSB antibodies.
    Franceschini F; Cavazzana I
    Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-La/SSB antibody is present in some normal sera and is coincident with anti-Ro/SSA precipitins in systemic lupus erythematosus.
    Harley JB; Yamagata H; Reichlin M
    J Rheumatol; 1984 Jun; 11(3):309-14. PubMed ID: 6204047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of anti-RNP antibody binding to cultured keratinocytes by estradiol.
    Furukawa F; Imamura S; Norris DA
    Arch Dermatol Res; 1991; 283(4):258-61. PubMed ID: 1929544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production.
    Meilof JF; Veldhoven CH; Swaak AJ; Smeenk RJ
    J Autoimmun; 1997 Feb; 10(1):67-75. PubMed ID: 9080301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody].
    Miyakata S; Takeuchi K; Yamaji K; Kanai Y; Tsuda H; Takasaki Y
    Ryumachi; 2001 Aug; 41(4):726-35. PubMed ID: 11577401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies: clinical correlations and biologic significance.
    Sontheimer RD; McCauliffe DP; Zappi E; Targoff I
    Adv Dermatol; 1992; 7():3-52; discussion 53. PubMed ID: 1371222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus.
    Tran HB; Macardle PJ; Hiscock J; Cavill D; Bradley J; Buyon JP; Gordon TP
    Arthritis Rheum; 2002 Jun; 46(6):1572-9. PubMed ID: 12115188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal lupus erythematosus in Japan: a review of the literature.
    Kobayashi R; Mii S; Nakano T; Harada H; Eto H
    Autoimmun Rev; 2009 May; 8(6):462-6. PubMed ID: 19162245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ro antibodies and neonatal lupus.
    Petri M; Watson R; Hochberg MC
    Rheum Dis Clin North Am; 1989 May; 15(2):335-60. PubMed ID: 2657894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. A new subset of lupus with characteristic skin manifestations].
    Bardach H
    Hautarzt; 1982 Oct; 33(10):537-41. PubMed ID: 6984040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.